Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
本文描述的化合物是溶血
磷脂受体的
拮抗剂。此外,还描述了包括本文所述化合物的药物组合物和药物,以及单独或与其他化合物联合使用此类
拮抗剂治疗 LPA 依赖性或 LPA 介导的病症或疾病的方法。